Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, October 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Wyatt Technology Instrumentation Employed by the Medical Research Council
Thursday, November 14, 2013
Wyatt's technology is being used to make advancements in tackling specific problems in human health and disease such as understanding different biophysical processes, including mechanisms of viral diseases and immunity.

GE Healthcare Life Sciences Launches Xuri™ Technology Family
Wednesday, November 13, 2013
First product introduced - Xuri Cell Expansion System W25 for the clinical manufacture of cellular immunotherapies.

Compact All-in-One Multiple Format Mixer
Tuesday, November 12, 2013
An accurate, reliable, compact and simple-to-use multi-format mixer.

Almac Launches New [14C]-labelled ADCs Service Offering
Monday, November 11, 2013
Antibody drug conjugates for the treatment of various cancer types.

iTAPP Declares Radiometer’s AQT90 FLEX a ‘High Impact Innovation’
Wednesday, November 06, 2013
AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing.

Abcam Introduces Alexa Fluor Secondary Antibodies
Tuesday, November 05, 2013
New range offers increased choice for multi-color staining.

Olink Bioscience Introduces Proseek Multiplex CVD I 96x96
Thursday, October 31, 2013
A 92 protein biomarker panel for cardiovascular disease.

AnaSpec Introduces SensoLyte® 520 TEV Protease Assay Kit
Thursday, October 31, 2013
TEV proteinase used to remove fusion tags from recombinant proteins.

Safe, Accurate, Easy Repeat Dispensing
Wednesday, October 30, 2013
Even for difficult to handle samples.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 358
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv